| CEO: | Carolyn Cross |
| Chairman: | Jean Charest |
| Chief Technology Officer: | Nicolas Loebel |
| Independent Non-Executive Director: | Junaid Bajwa |
| Senior Independent Non-Executive Director: | Jean Duvall |
| Non-Executive Dir: |
| Address: | 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6 |
| Phone: | +1 604 669 0555 |
| Website: | https://ondinebio.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | CA68234M2058 |
| Currency | UK Pounds |
| Share Price | 14.11p |
| Change Today | 1.11p |
| % Change | 8.57 % |
| 52 Week High | 18.00 |
| 52 Week Low | 8.00 |
| Volume | 463,943 |
| Shares Issued | 561.22m |
| Market Cap | £79.21m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:26 | 34,455 @ 14.50p |
| 11:25 | 65,812 @ 14.40p |
| 10:54 | 50,000 @ 13.70p |
| 10:46 | 50,000 @ 13.43p |
| 11:26 | 20,000 @ 14.00p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research